Analysis of BRAF and NRAS Mutation Status in Advanced Melanoma Patients Treated With Anti-Ctla-4 Antibodies: Association With Overall Survival?
Journal of Clinical Oncology - United States
doi 10.1200/jco.2013.31.15_suppl.9025
Full Text
Open PDFAbstract
Available in full text
Date
May 20, 2013
Authors
Publisher
American Society of Clinical Oncology (ASCO)